A review article led by researchers from the B·ARGO group at the Germans Trias i Pujol Research Institute (IGTP) and from the ...

A review article led by researchers from the B·ARGO group at the Germans Trias i Pujol Research Institute (IGTP) and from the Medical Oncology ...

After difficult chemotherapy, she switched to a regimen of biological drugs targeting a specific gene mutation. The new ...

A final discussion point is real-world applicability. Although PHAROS presents exceptional PFS, the modest difference between ...

Iovance Biotherapeutics targets significant market expansion, with lung cancer representing a $10B U.S. peak sales ...

Discover why Day One Biopharmaceuticals, Inc. is surging with Ojemda's growth, strategic deals, and key 2026 catalysts. Click ...

A York mum has told of the immense pride she has for her young son who is battling a rare form of brain cancer.

The cellular therapy landscape continues to evolve beyond hematologic malignancies, now making significant progress in solid ...

Renuka Iyer, M.D., will assume the role of CMO at NCCN, focusing on advancing evidence-based cancer care and guideline ...

Look back at the top 5 updates for oncology nurses and advanced practices providers published in 2025. From clinical updates ...

TABOSUN® (ipilimumab N01 injection) has been approved in combination with TYVYT® (sintilimab injection) for the neoadjuvant treatment of patients with stage IIB-III resectable microsatellite ...

Elicio Therapeutics, Inc. (Nasdaq: ELTX, 'Elicio” or the 'Company”), a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for the treatment of cancer, today announced ...